TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

P J Hesketh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.